The many faces of transforming growth factor-β in pleural diseases

Current Opinion in Pulmonary Medicine

Volumn 7, Issue 4, 2001, Pages 173-179

  Lee, Y C Gary ^a,c   Lane, Kirk B ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c SAINT THOMAS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

CARCINOGENESIS; CELL PROLIFERATION; CYTOKINE PRODUCTION; FIBROSIS; HUMAN; IMMUNOMODULATION; MESOTHELIUM CELL; NONHUMAN; PLEURA DISEASE; PLEURA EFFUSION; PLEURA FLUID; PLEURISY; PLEURODESIS; PROGNOSIS; REVIEW;

EID: 0034913843     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200107000-00001     Document Type: Review

References (102)

1. Role of transforming growth factor (β) in human disease
2. TGFβ-2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes
3. Transforming growth factor-β3 is required for secondary palate fusion
4. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein A mice
5. Tamoxifen elevates transforming growth factor-β and suppresses diet-induced formation of lipid lesions in mouse aorta
6. Blockade of transforming growth factor β/Smad signaling in T cells by overexpression of Smad 7 enhances antigen-induced airway inflammation and airway reactivity
7. Transforming growth factor-β1 in asthma: Measurement in bronchoalveolar lavage fluid
8. A single intrapleural injection of transforming growth factor β-2 produces an excellent pleurodesis in rabbits
9. Transforming growth factor-β2 induces pleurodesis significantly faster than talc
10. Transforming growth factor β-2 (TGFb2) produces effective pleurodesis in sheep with no systemic complications
11. Transforming growth factor β-2 induces pleurodesis in a novel pathway not inhibited by corticosteroids
12. Comparing transforming growth factor (TGF)-β2, talc and bleomycin as pleurodesing agents in sheep
13. Transforming growth factor (TGF)β2 induces vascular endothelial growth factor (VEGF) production by pleural mesothelial cells
14. Transforming growth factor β-2 but not fibronectin induces effective pleurodesis [Abstract]
15. Vascular endothelial growth factor level correlates with transforming growth factor β isoform levels in pleural effusions
16. Immunohistochemical localization of transforming growth factor β isoforms in asbestos-related diseases
17. A possible role of TGF-β in the formation of malignant effusions
18. Transforming growth factor-β in tissue fibrosis
19. Transforming growth factor-β
20. The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors
21. Transforming growth factor β gene maps to human chromosome 19 long arm and to mouse chromosome 7
22. Synthesis of messenger RNAs for transforming growth factors a and β and the epidermal growth factor receptor by human tumors
23. Genotype variation in the transforming growth factor-β1 gene
24. Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women
25. Association of a polymorphism of the transforming growth factor β-1 gene with prevalent vertebral fractures in Japanese women
26. Association of a T29 - > C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese
27. TGF-β1 DNA polymorphisms, protein levels, and blood pressure
28. Role of transforming growth factor β in cancer
29. The latent transforming growth factor β binding protein (LTBP) family
30. 125l-labeled transforming growth factor-type β from human platelets
31. TGF-β: From latent to active
32. 2-macroglobulin receptor-dependent mechanism for the plasma clearance for mice
33. 2-macroglobulin
34. Complex regulation of transforming growth factor β1, β2, and β3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factor β1 and β2
35. TGF-β receptor signaling
36. Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-β superfamily: Specialized binding sites for transforming growth factor-β and inhibin A
37. Importin β mediates nuclear translocation of Smad 3
38. Smads: Transcriptional activators of TGF-β responses
39. A mechanism of suppression of TGF-β/SMAD signaling by NF-kB/RelA
40. Positive and negative regulation of TGF-β signaling
41. TGFβ signaling in growth control, cancer and inheritable disorders
42. Controlling TGF-β signaling
43. TGF-β1 and radiation fibrosis: A master switch and a specific therapeutic target?
44. 1 induces prolonged severe fibrosis in rat lung
45. TGF-β and fibrosis
46. Active transforming growth factor-β in wound repair: Determination using a new assay
47. Fibrogenesis: TGF-β signaling pathways
48. Pleural cell biology in health and disease
49. Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells: Cellular differentiation influences expression
50. Mesothelial cell modulation of pleural repair: Thrombin stimulated mesothelial cells release prostaglandin E2
51. Collagen-producing mesothelial cells in adriamycin-induced pleuritis in rat: Microautoradiographic study utilizing tritiated proline
52. Collagen production by human mesothelial cells in vitro
53. Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells
54. Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-β1
55. Hyperosmolality suppresses but TGF β1 increases MMP9 in human peritoneal mesothelial cells
56. Differential regulation of mesothelial cells fibrinolysis by transforming growth factor β1
57. Pathways of fibrin turnover of human pleural mesothelial cells in vitro
58. Pleurodesis for recurrent pleural effusions in the new millenium
59. Talc slurry pleurodesis: Pleural fluid and histologic analysis
60. Phase I trial of transforming growth factor β2 in chronic progressive MS
61. Transforming growth factor (TGF)β2 decreases while talc stimulates IL-8 production from mesothelial cells
62. Systemic corticosteroids decrease the effectiveness of talc pleurodesis
63. Local production and localization of transforming growth factor-β in tuberculous pleurisy
64. Reduction of bleomycin induced lung fibrosis by transforming growth factor soluble receptor in hamsters
65. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1
66. Control of scarring in adult wounds by neutralising antibody to transforming growth factor β
67. Formation of abdominal adhesions is inhibited by antibodies to transforming growth factor-β1
68. Transient gene transfer and expression of Smad 7 prevents bleomycin-induced lung fibrosis in mice
69. Manipulation of TGF-β to control autoimmune and chronic inflammatory diseases
70. The transforming growth factor-βs
71. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth
72. Transforming growth factor-β inhibits E-selectin expression on human endothelial cells
73. Deactivation of macrophages by transforming growth factor-β
74. Transforming growth factor-β1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis
75. Regulation of cytokine release by alveolar macrophages treated with intedeukin-4, interleukin-10, or transforming growth factor β
76. Transforming growth factor-β1 inhibits synthesis of cytokines in endotoxin-stimulated human whole blood
77. Induction by transforming growth factor-β1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells
78. Interleukin-4 and transforming growth factor-β1 modulate the production of interleukin-1 receptor antagonist and of prostaglandin E2 by decidual cells
79. Transforming growth factor-β1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium
80. Early-onset multifocal inflammation in the transforming growth factor β1-null mouse is lymphocyte mediated
81. Effect of cytokines on regulation of the production of transforming growth factor β-1 in cultured human Tenon's capsule fibroblasts
82. Transforming growth factor-β synthesis by human peritoneal mesothelial cells. Induction by interleukin-1
83. Interleukin-1 β stimulates the production of extracellular matrix in cultured human peritoneal mesothelial cells
84. Inhibition of rat pleural mesothelial cell nitric oxide synthesis by transforming growth factor-β1
85. Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice
86. Plasmid DNA encoding transforming growth factor-β1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model
87. Transforming growth factor-β and cancer: A love-hate relationship?
88. The role of transforming growth factor-β (TGF-β) in human cancer
89. 2 inhibit the growth of malignant mesothelioma both in vitro and in vivo
90. Transforming growth factor-β1 (TGFβ1) and β2 like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer
91. Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients
92. Molecular and biological properties of vascular endothelial growth factor
93. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation
94. Expression of vascular endothelial growth factor in human monocyte/macrophages stimulated with lipopolysaccharides
95. Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release
96. TGF-β1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis
97. Plasma transforming growth factor-β1 in patients with hepatocellular carcinoma: Comparison with chronic liver diseases
98. Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer
99. Serum transforming growth factor-β1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease
100. Transforming growth factor β2 (TGF-β2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen
101. Plasma transforming growth factor-β-1 reflects disease status in patients with lung cancer after radiotherapy: A possible tumor marker
102. Plasma transforming growth factor-β1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma